Business
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference\nPR Newswire\nSAN DIEGO, June 11, 2020\n\n\n\nSAN DIEGO, June 11, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde and Caroline Heinz, co-CEOs of its subsidiary HempMeds®, have been invited to speak at The Global Cannabis Summit. This virtual conference will take place on June 27-29.\nTogether, Elizalde and Heinz will speak on the cannabis industry landscape throughout Latin America and how they plan to apply their experience pioneering change there to spearhead legislation and sales efforts in the U.S. and around the world in their new roles.\n\"While we have made great progress around the world, there are still many families without crucial access to hemp-based cannabidiol (CBD). I am humbled for this opportunity to continue educating audiences on the regulatory landscape of cannabis across Latin America and how we can work together to create lasting change,\" said Raul Elizalde, co-CEO of HempMeds®.\nElizalde served as President of HempMeds® Mexico and Latin American operations for several years prior to his promotion to co-CEO of HempMeds®. In that position, he significantly grew the Company's presence and sales throughout Latin America, especially in Mexico. Notably, in 2017, he played a key role in legalizing the import of CBD into Mexico.\n\"Education is a key missing element in the global movement for CBD legalization. Through events like this one, we are able to continue sharing our knowledge and advocating for expanded access to CBD,\" said Caroline Heinz, co-CEO of HempMeds®.\nHeinz joine...